Modulating the interaction between HGF beta chain and c-met

Details for Australian Patent Application No. 2004252475 (hide)

Owner Genentech, Inc.

Inventors Yao, Xiaoyi; Lazarus, Robert A.; Kirchhofer, Daniel K.

Agent Griffith Hack

Pub. Number AU-A-2004252475

PCT Pub. Number WO2005/001486

Priority 60/476,778 06.06.03 US; 60/532,117 23.12.03 US

Filing date 4 June 2004

Wipo publication date 6 January 2005

International Classifications

G01N 33/74 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving hormones

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2005/001486 Priority application(s): WO2005/001486

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004252479-Transcription factors

2004252465-Preparation and application of anti-tumor bifunctional fusion proteins